Your browser is no longer supported. Please, upgrade your browser.
RMTI [NASD]
Rockwell Medical, Inc.
Index- P/E- EPS (ttm)-0.35 Insider Own2.90% Shs Outstand93.88M Perf Week26.81%
Market Cap47.86M Forward P/E- EPS next Y-0.29 Insider Trans0.00% Shs Float91.24M Perf Month24.15%
Income-32.40M PEG- EPS next Q-0.07 Inst Own30.80% Short Float1.98% Perf Quarter-12.00%
Sales61.80M P/S0.77 EPS this Y27.10% Inst Trans-0.05% Short Ratio0.77 Perf Half Y-35.61%
Book/sh0.12 P/B4.24 EPS next Y9.40% ROA-48.10% Target Price5.00 Perf Year-60.23%
Cash/sh0.35 P/C1.44 EPS next 5Y38.00% ROE-144.60% 52W Range0.34 - 1.98 Perf YTD24.15%
Dividend- P/FCF- EPS past 5Y-7.20% ROI- 52W High-74.29% Beta0.81
Dividend %- Quick Ratio1.90 Sales past 5Y2.40% Gross Margin0.30% 52W Low48.83% ATR0.05
Employees300 Current Ratio2.10 Sales Q/Q4.60% Oper. Margin-48.60% RSI (14)65.80 Volatility17.96% 11.72%
OptionableYes Debt/Eq2.03 EPS Q/Q21.10% Profit Margin-52.50% Rel Volume1.14 Prev Close0.47
ShortableYes LT Debt/Eq1.27 EarningsNov 15 AMC Payout- Avg Volume2.34M Price0.51
Recom2.00 SMA2024.03% SMA5016.56% SMA200-25.59% Volume2,654,164 Change8.30%
Jun-24-19Initiated Piper Jaffray Overweight $10
May-13-19Initiated H.C. Wainwright Buy $11
Nov-08-16Downgrade BofA/Merrill Neutral → Underperform
Mar-01-16Downgrade Stifel Buy → Hold
Aug-13-15Initiated Morgan Stanley Underweight $7
Jan-27-15Reiterated Oppenheimer Outperform $24 → $26
Jan-07-15Initiated Oppenheimer Outperform $24
Aug-14-14Initiated FBR Capital Underperform $6
Dec-19-13Initiated Chardan Capital Markets Buy $22
Nov-06-13Reiterated Summer Street Research Buy
Sep-05-13Reiterated Summer Street Research Buy $20 → $25
Aug-02-13Reiterated Summer Street Research Buy $20
Apr-11-12Initiated Summer Street Research Buy $20
Mar-12-12Initiated Stifel Nicolaus Buy $15
Jan-03-12Initiated Canaccord Genuity Buy $14
Dec-10-09Initiated JMP Securities Mkt Outperform $11
Oct-12-09Initiated Wedbush Morgan Outperform $12
Jan-14-22 03:05PM  
Jan-13-22 11:42AM  
08:21AM  
Jan-07-22 12:00PM  
Dec-14-21 09:00AM  
Nov-17-21 02:39PM  
10:43AM  
07:35AM  
06:43AM  
Nov-16-21 04:01PM  
Nov-15-21 05:15PM  
04:00PM  
Nov-12-21 04:05PM  
Nov-11-21 08:30AM  
Nov-08-21 07:00AM  
Nov-04-21 04:01PM  
Nov-01-21 03:01PM  
Sep-09-21 09:52AM  
Aug-19-21 04:00PM  
06:58AM  
Aug-16-21 06:35PM  
04:09PM  
Aug-09-21 03:00PM  
Jul-29-21 07:00AM  
Jun-28-21 07:00AM  
Jun-18-21 12:52PM  
Jun-14-21 08:07AM  
Jun-11-21 12:20PM  
Jun-08-21 07:00AM  
Jun-07-21 09:29AM  
Jun-03-21 07:00AM  
May-17-21 04:05PM  
02:45PM  
May-03-21 07:00AM  
Apr-27-21 07:00AM  
Apr-26-21 06:29AM  
Apr-22-21 04:05PM  
Apr-06-21 10:08AM  
Mar-31-21 05:45PM  
04:05PM  
02:30PM  
Mar-26-21 12:34PM  
Mar-24-21 12:30PM  
Mar-18-21 07:00AM  
Mar-17-21 08:34AM  
Mar-04-21 12:30PM  
07:00AM  
Feb-09-21 01:45PM  
07:00AM  
Feb-01-21 08:08AM  
07:00AM  
Jan-14-21 08:47AM  
Jan-13-21 07:00AM  
Jan-05-21 07:00AM  
Dec-16-20 07:00AM  
Dec-02-20 04:07AM  
Nov-29-20 04:57PM  
Nov-09-20 05:02PM  
04:05PM  
02:30PM  
Nov-02-20 12:30PM  
Oct-27-20 08:00AM  
Oct-13-20 08:00AM  
Sep-24-20 06:09PM  
Sep-23-20 08:45AM  
Sep-22-20 09:52AM  
08:48AM  
Sep-21-20 03:30PM  
Sep-15-20 07:59AM  
Sep-11-20 10:09AM  
Sep-10-20 09:52AM  
07:20AM  
Sep-09-20 04:15PM  
08:00AM  
Sep-08-20 08:00AM  
Aug-27-20 02:49PM  
Aug-10-20 06:35PM  
04:05PM  
Aug-03-20 04:05PM  
Jun-17-20 08:43AM  
Jun-10-20 04:30PM  
May-27-20 12:43PM  
May-26-20 07:00AM  
May-11-20 08:05PM  
04:05PM  
May-07-20 12:30PM  
Apr-20-20 08:30AM  
Mar-31-20 04:30PM  
Mar-27-20 11:21AM  
Mar-25-20 04:01PM  
Mar-22-20 02:25PM  
Mar-20-20 08:30AM  
Mar-18-20 09:42AM  
Mar-17-20 06:50AM  
Mar-16-20 08:00AM  
Mar-12-20 07:05PM  
04:05PM  
03:33PM  
02:30PM  
Mar-11-20 08:30AM  
Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. The company's dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. It is also developing other therapeutic product candidates for the treatment of hospitalized patients with acute heart failure; and home infusion therapy that allows patients to receive intravenous medications at home. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include medium and small sized dialysis chains and independent dialysis centers. Rockwell Medical, Inc. was incorporated in 1996 and is headquartered in Wixom, Michigan.